Moreover, studies indicate that 8-aza can reduce tumor malignancy by inhibiting RAS-mediated regulation of ADAR1 via the PI3K pathway [397], suggesting a potential direction for therapies targeting A-to-I RNA editing. Here, ADAR is linked to neoplasm.